Ryan Savitz
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ryan Savitz
Ryan Savitz is recorded as CFO and Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH). Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 12, 2023 that Ryan Savitz was appointed Treasurer and Chief Financial Officer and principal financial officer, effective September 11, 2023. The proxy statement of Dianthus Therapeutics, Inc. /DE/ reports total compensation of $5,074,953 for Ryan Savitz in fiscal 2025, including a base salary of $482,560. Disclosed compensation is on record for 3 fiscal years.
“On September 11, 2023, the Board of Directors appointed Marino Garcia as the Company's President and Chief Executive Officer and principal executive officer, Ryan Savitz as the Company's Treasurer and Chief Financial Officer and principal financial officer and Edward Carr as the Company's Chief Accounting Officer and principal accounting officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Dianthus Therapeutics, Inc. /DE/
Other people whose current roles at this company are on record from its filings.
- Marino Garcia CEO, Board Member
- Alison F. Lawton Chairman
- Leon O. Moulder, Jr. Chairman, Board Member
- Steve Mahoney CFO
- Edward Carr Chief Accounting Officer, Board Member
- Adam Veness Board Member
- Anne McGeorge Board Member
- Jonathan Violin Board Member
- Jonathan Violin, Ph.D. Board Member
- Lei Meng Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Executive Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | $482,560 | $5,074,953 |
| 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Chief Financial Officer, Chief Business Officer and Treasurer | $464,000 | $4,002,145 |
| 2023 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Chief Financial Officer, Chief Business Officer and Treasurer | $135,511 | $329,651 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.